- Report
- March 2024
- 190 Pages
Global
From €3262EUR$3,374USD£2,804GBP
€3624EUR$3,749USD£3,115GBP
- Report
- April 2024
- 194 Pages
Global
From €4785EUR$4,950USD£4,113GBP
- Report
- January 2024
- 145 Pages
Global
From €3769EUR$3,899USD£3,240GBP
- Report
- January 2024
- 206 Pages
Global
€4829EUR$4,995USD£4,150GBP
- Report
- January 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- April 2024
Global
From €2852EUR$2,950USD£2,451GBP
- Report
- February 2024
- 468 Pages
Global
From €4639EUR$4,799USD£3,988GBP
- Report
- August 2023
- 120 Pages
Global
From €2320EUR$2,400USD£1,994GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- February 2024
- 250 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- February 2024
- 250 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- February 2024
- 250 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- December 2023
- 200 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- April 2024
- 224 Pages
Global
From €4785EUR$4,950USD£4,113GBP
- Report
- February 2024
- 210 Pages
Global
From €3480EUR$3,600USD£2,991GBP
- Report
- February 2024
- 188 Pages
Global
From €3480EUR$3,600USD£2,991GBP
- Report
- June 2023
- 241 Pages
Global
From €7250EUR$7,500USD£6,232GBP
Immune Checkpoint Inhibitor drugs are a type of immunotherapy used to treat immune disorders. They work by blocking proteins that act as “checkpoints” in the immune system, allowing the body to recognize and attack cancer cells. These drugs are used to treat a variety of cancers, including melanoma, non-small cell lung cancer, and bladder cancer. They are also used to treat autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease.
Immune Checkpoint Inhibitor drugs are a relatively new form of treatment, and the market is still in its early stages. However, the potential of these drugs has led to a surge in research and development, with many companies investing in the development of new drugs.
Some of the major companies in the Immune Checkpoint Inhibitor market include Bristol-Myers Squibb, Merck, AstraZeneca, Roche, and Novartis. Other companies such as Pfizer, AbbVie, and Johnson & Johnson are also involved in the development of these drugs. Show Less Read more